Supporting our data, a bioinformatics study predicted HAPLN1 expression to lie downstream upregulated Wnt/β-catenin signaling in colorectal cancer [38] and proteomics analysis of tumor stroma reported HAPLN1 in highly metastatic melanomas [25]. The gene discussed is HAPLN1; the disease is colorectal cancer.